Elizabeth Anne Eady

Elizabeth Anne Eady

Auto-generated profile, based on publicly available information

Elizabeth Anne Eady

Department of Dermatology, Harrogate and District NHS Foundation Trust, Harrogate, UK

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2005 in Experimental Dermatology
Verified
Journal Article
Open access
PDF file
Christos C. ZouboulisChristos C. Zouboulis
Christos C. Zouboulis
AEA. Eady
A. Eady
MPM. Philpott
M. Philpott
LGL. A. Goldsmith
L. A. Goldsmith
COC. Orfanos
C. Orfanos
RRR. Rosenfield
R. Rosenfield
Abstract:  For a long time, the mantra of acne pathogenesis debates has been that acne vulgaris lesions develop when (supposedly largely androgen‐mediated) increased sebum production, ductal hypercornification, and propionibacteria come together with local inflammatory process in the unlucky affected individual. And yet, the exact sequence, precise interdependence, and choreography of pathogenic events in acne, especially the ‘match that lights the fire’ have remained surprisingly unclear, despite the venerable tradition of acne research over the past century.However, exciting recent progress in this – conceptually long somewhat stagnant, yet clinically, psychologically, and socioeconomically highly relevant – everyday battlefield of skin pathology encourages one to critically revisit conventional concepts of acne pathogenesis. Also, this provides a good opportunity for defining more sharply key open questions and intriguing acne characteritics whose underlying biological basis has far too long remained uninvestigated, and to emphasize promising new acne research avenues off‐the‐beaten‐track – in the hope of promoting the corresponding development of innovative strategies for acne management.

1 April 2003 in Current Opinion in Infectious Diseases
Verified
Journal Article
Closed access
EEE. Anne Eady
E. Anne Eady
JCJonathan H. Cove
Jonathan H. Cove
In the community non-localized or deep staphylococcal skin and soft tissue infections are typically managed with beta-lactamase stable penicillins. The aims of this review are (1) to evaluate the evidence for the emergence of new strains of community-acquired methicillin resistant Staphylococcus aureus (MRSA), (2) to identify the reasons for their significant association with cutaneous infections, and (3) to consider how they arose and how big a threat they pose to the management of such infections outside hospitals. MRSA are emerging as significant community pathogens, especially in previously healthy children with no recognizable risk factors, and are predominantly associated with skin and soft tissue infections (especially abscesses and cellulitis). When present, risk factors are generally similar to those for infection with methicillin susceptible S. aureus. The MRSA isolates associated with such infections may not be entirely 'new', but could represent the displacement of some hospital clones (e.g. EMRSA-15 or variants thereof) to the community as well as the de-novo generation of novel MRSA clones by multiple horizontal transmissions of the mecA gene into methicillin susceptible S. aureus with different genetic backgrounds, some of which are already circulating globally. Community-acquired MRSA from diverse locations are non multiresistant and almost always contain the novel type IV SCCmec commonly found in coagulase-negative staphylococci, but also in hospital-associated gentamicin susceptible MRSA from France, the paediatric clone and in EMRSA-15. More local data on CA-MRSA infections are needed so that dermatologists and community physicians can assess the risk of such infections amongst their patients and avoid the inappropriate administration of beta-lactams. No simple change in prescribing practices will entirely alleviate selective pressure for the spread of community-acquired MRSA and not exacerbate resistance in pyogenic streptococci, commonly found together with S. aureus in skin and soft tissue infections. The importance of hygiene in preventing the spread of community-acquired MRSA in the community must be reemphasized.

30 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Andrew McdowellAndrew Mcdowell
Andrew Mcdowell
EBEmma Barnard
Emma Barnard
INIstván Nagy
István Nagy
AGAnna Gao
Anna Gao
STShuta Tomida
Shuta Tomida
SPSheila Patrick
Sheila Patrick
The Gram-positive bacterium Propionibacterium acnes is a member of the normal human skin microbiota and is associated with various infections and clinical conditions. There is tentative evidence to suggest that certain lineages may be associated with disease and others with health. We recently described a multilocus sequence typing scheme (MLST) for P. acnes based on seven housekeeping genes (http://pubmlst.org/pacnes). We now describe an expanded eight gene version based on six housekeeping genes and two ‘putative virulence’ genes (eMLST) that provides improved high resolution typing (91eSTs from 285 isolates), and generates phylogenies congruent with those based on whole genome analysis. When compared with the nine gene MLST scheme developed at the University of Bath, UK, and utilised by researchers at Aarhus University, Denmark, the eMLST method offers greater resolution. Using the scheme, we examined 208 isolates from disparate clinical sources, and 77 isolates from healthy skin. Acne was predominately associated with type IA1 clonal complexes CC1, CC3 and CC4; with eST1 and eST3 lineages being highly represented. In contrast, type IA2 strains were recovered at a rate similar to type IB and II organisms. Ophthalmic infections were predominately associated with type IA1 and IA2 strains, while type IB and II were more frequently recovered from soft tissue and retrieved medical devices. Strains with rRNA mutations conferring resistance to antibiotics used in acne treatment were dominated by eST3, with some evidence for intercontinental spread. In contrast, despite its high association with acne, only a small number of resistant CC1 eSTs were identified. A number of eSTs were only recovered from healthy skin, particularly eSTs representing CC72 (type II) and CC77 (type III). Collectively our data lends support to the view that pathogenic versus truly commensal lineages of P. acnes may exist. This is likely to have important therapeutic and diagnostic implications.

1 May 2002 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PCP. Coates
P. Coates
SVS. Vyakrnam
S. Vyakrnam
EEE.A. Eady
E.A. Eady
CJC.E. Jones
C.E. Jones
JCJ.H. Cove
J.H. Cove
WCW.J. Cunliffe
W.J. Cunliffe

1 June 1992 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
EIEileen Ingham
Eileen Ingham
EEE Anne Eady
E Anne Eady
CGChristina E Goodwin
Christina E Goodwin
JCJonathan H Cove
Jonathan H Cove
WCWilliam J Cunliffe
William J Cunliffe

1 January 1993 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
PDF file
EEE. Anne Eady
E. Anne Eady
JRJeremy I. Ross
Jeremy I. Ross
Joanne TipperJoanne Tipper
Joanne Tipper
CWChristina E. Walters
Christina E. Walters
JCJonathan H. Cove
Jonathan H. Cove
WNWilliam C. Noble
William C. Noble
Erythromycin-resistant staphylococci can be divided into two phenotypic classes based on their pattern of cross-resistance to other macrolides, lincosamides and type B streptogramins. Strains inducibly or constitutively resistant to all MIS antibiotics possess erythromycin ribosomal methylase (erm) genes, whereas strains inducibly resistant to only 14 and 15-membered ring macrolides and type B streptogramins harbour msrA. which encodes an ATP-dependent efflux pump. Dot-blot hybridization was used to study the distribution of ermA, ermB, ermC and msrA in five epidemiologically distinct groups of staphylococci. The most widely-distributed resistance determinant was ermC, which was detected in 112 (50·6%) of 221 isolates, alone in 106 isolates and in combination with a second erythromycin resistance determinant in six strains. MsrA was detected in 73 (33%) of isolates, alone in 65 and in combination with a methylase gene in eight strains. This determinant was responsible for erythromycin resistance in over one-third (36·4%) of clinical isolates of coagulase-negative staphylococci. ErmA and ermB were present in only a minority of isolates (5·9 and 7·2% of strains, respectively). The resistance determinants present in ten strains did not hybridize to any of the four probes although, in all cases, their resistance phenotype was consistent with the possession of a methylase gene. Interestingly, ermB was found exclusively in animal isolates of Staphylococcus intermedius, Staphylococcus xylosus and Staphylococcus hyicus, but not in coagulase-negative staphylococci of human origin. This determinant has previously only been found in a small number of epidemiologically related strains of Staphylococcus aureus.